EN
登录

加拿大制药公司推出一种治疗高血压的新仿制药

Pharmascience Canada launches a new generic drug to treat hypertension

BioSpace 等信源发布 2023-09-05 10:14

可切换为仅中文


[05-September-2023]

[2023年9月5日]

MONTREAL, Sept. 5, 2023 /CNW/ - pms-PERINDOPRIL-INDAPAMIDE (perindopril erbumine / indapamide) is used in adults for the initial treatment of mild to moderate essential hypertension (high blood pressure).

蒙特利尔,2023年9月5日/CNW/-pms培哚普利吲达帕胺(培哚普利-艾伯明/吲达帕胺)用于成人,用于轻度至中度原发性高血压(高血压)的初始治疗。

pms-PERINDOPRIL-INDAPAMIDE (perindopril erbumine/ indapamide) are a combination of perindopril erbumine, an angiotensin converting enzyme (ACE) inhibitor, and indapamide, a chlorosulphamoyl diuretic. These two active ingredients act synergistically to lower blood pressure in hypertensive patients of all ages..

pms培哚普利-吲达帕胺(培哚普利-麦角胺/吲达帕胺)是血管紧张素转换酶(ACE)抑制剂培哚普利-麦角胺和氯磺酰利尿剂吲达帕胺的组合。这两种活性成分协同作用,降低所有年龄段高血压患者的血压。。

pms-PERINDOPRIL-INDAPAMIDE comes in the following dosage forms:

pms培哚普利吲达帕胺有以下剂型:

Tablets of 2 mg perindopril erbumine/ 0.625 mg indapamide.

2 mg培哚普利-erbumin/0.625 mg吲达帕胺片。

Tablets of 4 mg perindopril erbumine/ 1.25 mg indapamide.

4 mg培哚普利-erbumin/1.25 mg吲达帕胺片。

Tablets of 8 mg perindopril erbumine/ 2.5 mg indapamide.

8 mg培哚普利-erbumin/2.5 mg吲达帕胺片。

pms-PERINDOPRIL-INDAPAMIDE is a generic equivalent to Coversyl® Plus, Coversyl® Plus LD and Coversyl® Plus HD and has the same safety and efficacy as Coversyl®. pms-PERINDOPRIL-INDAPAMIDE tablets are offered at a lower price than brand-name products.

pms培哚普利吲达帕胺是与Coversyl®Plus,Coversyl®Plus LD和Coversyl®Plus HD相当的通用产品,具有与Coversyl®相同的安全性和有效性。pms培哚普利吲达帕胺片的价格低于名牌产品。

'The Pharmascience team is happy to bring to market pms-Perindopril-Indapamide used for the initial treatment of high blood pressure. The availability of pms-Perindopril-Indapamide gives every Canadian an affordable and important treatment option! At Pharmascience, we take tremendous pride in our locally produced medicines and will continue to focus on growing our portfolio with quality medications needed for all Canadians!' - mentioned Mike Dutton, Vice President, and General Manager of Pharmascience Canada. .

'制药团队很乐意将用于高血压初始治疗的pms培哚普利吲达帕胺推向市场。pms-培哚普利-吲达帕胺的可用性为每个加拿大人提供了一种负担得起的重要治疗选择!在Pharmascience,我们对当地生产的药物感到非常自豪,并将继续关注增长我们的产品组合,为所有加拿大人提供所需的优质药物!-提到Mike Dutton,副总裁和加拿大制药科学总经理。 .

ABOUT PHARMASCIENCE INC.

关于制药公司。

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries.

Pharmascience Inc.成立于1983年,是魁北克最大的制药雇主,拥有1500名员工,自豪地总部设在蒙特利尔。Pharmascience Inc.是一家全方位私营制药公司,在加拿大拥有悠久的根,在50多个国家/地区拥有日益增长的全球产品分布。

Ranked 50th among Canada's top 100 Research & Development (R&D) investors in 2022, with 40-50 million dollars invested each year, Pharmascience Inc. is among the largest drug manufacturers in Canada. .

在2022年加拿大前100名研发(R&D)投资者中排名第50,每年投资4000万至5000万美元,Pharmascience Inc.是加拿大最大的药品制造商之一。 .

Pharmascience Inc. has strong values based on the importance of investing in its employees and young people. Through various programs and initiatives, the company ensures it supports their personal development and life. In 2023, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada's Top Employers for Young People as part of Canada's Top 100 Employers.

基于投资员工和年轻人的重要性,Pharmascience Inc.具有强大的价值观。通过各种计划和举措,公司确保支持他们的个人发展和生活。2023年,Pharmascience Inc.因其投资而自豪地获得认可,被选为加拿大年轻人的顶级雇主之一,成为加拿大前100名雇主的一部分。

Pharmascience is now certified as a Great Place to Work for a second year in a row.  .

Pharmascience现在被认证为连续第二年工作的好地方。  .

For product information, please contact Pharmascience's Medical Information Department at 1-888-550-6060.

有关产品信息,请致电1-888-550-6060联系Pharmascience的医疗信息部门。

Coversyl® Plus, Coversyl® Plus LD and Coversyl® Plus HD are registered trademark owned by Servier Canada Inc.

Coversyl®Plus,Coversyl®Plus LD和Coversyl®Plus HD是Servier Canada Inc.拥有的注册商标。

SOURCE Pharmascience Inc.

资料来源:制药科学公司。